Results 11 to 20 of about 23,501 (253)

EHS and AHS guidelines for treatment of primary ventral hernias in rare locations or special circumstances

BJS Open, Volume 4, Issue 2, Page 342-353, April 2020., 2020
This guideline addresses the treatment of umbilical and epigastric hernias in clinically challenging situations (cirrhosis, dialysis, subsequent pregnancy, rectus diastasis), as well as the treatment of Spigelian and primary lumbar hernias. Emphasises the need for better evidence Background Rare locations of hernias, as well as primary ventral hernias ...
N. A. Henriksen, R. Kaufmann, M. P. Simons, F. Berrevoet, B. East, J. Fischer, W. Hope, D. Klassen, R. Lorenz, Y. Renard, M. A. Garcia Urena, A. Montgomery, on behalf of the European Hernia Society and the Americas Hernia Society   +12 more
wiley   +1 more source

Factores asociados a la mortalidad en pacientes cirróticos

Revista Cubana de Medicina Militar, 2021
Introducción: La cirrosis hepática representa en Perú el 9,1 % de las causas de mortalidad. Existe poca evidencia sobre la influencia de variables epidemiológicas y clínicas en la mortalidad de pacientes con cirrosis hepática en Latinoamérica, en ...
Maricarmen Viera Santillán, Luis Vasquez Elera, Christopher Valdiviezo Morales, Raisa Martinez Rivera, Mario Valladares Garrido   +4 more
doaj   +2 more sources

Whole‐body MRI for preventive health screening: A systematic review of the literature

Journal of Magnetic Resonance Imaging, Volume 50, Issue 5, Page 1489-1503, November 2019., 2019
Background The yield of whole‐body MRI for preventive health screening is currently not completely clear. Purpose To systematically review the prevalence of whole‐body MRI findings in asymptomatic subjects. Study Type Systematic review and meta‐analysis. Subjects MEDLINE and Embase were searched for original studies reporting whole‐body MRI findings in
Robert M. Kwee, Thomas C. Kwee
wiley   +1 more source

Criterios para seleccionar a los pacientes infectados por el VHC que son candidatos al tratamiento antiviral [PDF]

, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/100294/1/cld264 ...
Botero, Rafael Claudino
core   +1 more source

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling

Cancer Medicine, Volume 7, Issue 3, Page 796-808, March 2018., 2018
Our results suggest elevated TRIM44 promote ICC development by inducing cell EMT and apoptosis resistance, and TRIM44 is a valuable prognostic biomarker and promising therapeutic target of ICC. Abstract Surgical results for intrahepatic cholangiocarcinoma (ICC) remain unsatisfactory due to the high rate of recurrence.
Rui Peng, Peng‐Fei Zhang, Chi Zhang, Xiao‐Yong Huang, Yan‐bing Ding, Bin Deng, Dou‐Sheng Bai, Ya‐Ping Xu   +7 more
wiley   +1 more source

Síndrome hepatorrenal: fisiopatología, diagnóstico y manejo

Revista Colombiana de Gastroenterología, 2017
El síndrome hepatorrenal es la forma de disfunción renal que complica a los pacientes con enfermedad hepática avanzada o insuficiencia hepática aguda.
Juan Ricardo Ospina, Juan Carlos Restrepo   +1 more
doaj   +1 more source

Use of Left Gastric Vein as an Alternative for Portal Flow Reconstruction in Liver Transplantation

Case Reports in Surgery, Volume 2016, Issue 1, 2016., 2016
Portal vein thrombosis is observed in up to 10% of liver transplant candidates, hindering execution of the procedure. A dilated gastric vein is an alternative to portal vein reconstruction and decompression of splanchnic bed. We present two cases of patients with portal cavernoma and dilated left gastric vein draining splanchnic bed who underwent liver
Uirá Fernandes Teixeira, Mayara Christ Machry, Marcos Bertozzi Goldoni, Cristine Kruse, João Alfredo Diedrich, Pablo Duarte Rodrigues, Caroline Becker Giacomazzi, Estéfano Aurélio Negri, Matheus Koop, Carlos Gustavo Spode Gomes, José Artur Sampaio, Paulo Roberto Ott Fontes, Fábio Luiz Waechter, Gaetano La Greca   +13 more
wiley   +1 more source

La esteatohepatitis no alcohólica: una causa emergente de cirrosis en Colombia

Revista Colombiana de Gastroenterología, 2022
Introducción: la cirrosis hepática es una importante causa de morbimortalidad en América Latina; el incremento de la prevalencia del síndrome metabólico en nuestra población podría estar cambiando el perfil epidemiológico de los pacientes con enfermedad
Juan David Vélez Aguirre, Lourdes Helene Lepesqueur Guillén, Ismael de Jesús Yepes Barreto   +2 more
doaj   +1 more source

Hepatitis C Virus Infection: Looking for Interferon Free Regimens

The Scientific World Journal, Volume 2013, Issue 1, 2013., 2013
Recent developments of new drugs′ combinations are changing the treatment paradigm in hepatitis C virus infection. Due to the side effect profile of pegylated interferons, interferon‐sparing regimens have become the main target in chronic hepatitis C treatment research.
J. González-Moreno, A. Payeras-Cifre, Han Chieh Lin, Sheng-Nan Lu   +3 more
wiley   +1 more source

La carga de la enfermedad por cirrosis hepática en México

Gaceta Médica de México, 2023
Antecedentes: La cirrosis hepática es una causa importante de morbilidad y mortalidad en el mundo. En México, constituye una las primeras seis causas de muerte.
Nayelli C. Flores-García, Mae Dirac, Hannah Han, David Kershenobich-Stalnikowitz   +3 more
doaj   +1 more source